{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:03:01Z","timestamp":1789041781430,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000195"],"award-info":[{"award-number":["82000195"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M721981"],"award-info":[{"award-number":["2022M721981"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taishan Scholars Program of Shandong Province","award":["tsqn201909184"],"award-info":[{"award-number":["tsqn201909184"]}]},{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["ZR2024MH050"],"award-info":[{"award-number":["ZR2024MH050"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shandong Provincial Health Construction Program of Medical Science and Technology Innovation Team"},{"name":"Academic Promotion Programme of Shandong First Medical University","award":["2020RC007"],"award-info":[{"award-number":["2020RC007"]}]},{"name":"Research Promotion Program of Shandong Provincial Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Fatty acids serve as a crucial energy source for tumor cells during the progression of chronic lymphocytic leukemia (CLL). The present study aims to elucidate the characteristics of fatty acid metabolism (FAM) in CLL, construct a related prognostic score, and investigate the regulatory role and mechanisms of FAM in CLL development.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Bulk RNA sequencing data from CLL patients and healthy controls were analyzed to identify differentially expressed fatty acid metabolic genes. <jats:italic>FAM-score<\/jats:italic> was constructed using Cox-LASSO regression and validated. Single-cell RNA sequencing was used to analyze the expression of key FAM genes in CLL immune cell subsets and investigate cellular communication. Functional assays, including cell viability, drug sensitivity, and oxygen consumption assays, were performed to assess the impact of fatty acid oxidation (FAO) inhibition on CLL cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Three FAM-related genes (LPL, SOCS3, CNR1) were identified with independent prognostic significance to construct the risk score. The <jats:italic>FAM-score<\/jats:italic> demonstrated superior prognostic performance compared to the Binet stage and was associated with established clinical prognostic markers. Single-cell analysis revealed distinct expression patterns of LPL, SOCS3, and CNR1 across CLL immune cell subsets. Cellular communication analysis highlighted the regulatory role of distinct B cell and Treg subsets in the CLL microenvironment. CLL patients with high <jats:italic>FAM-score<\/jats:italic> displayed distinct immune infiltration patterns, with increased FAO pathway activity. Inhibition of FAO reduced CLL cell viability, synergistically enhanced the efficacy of the PI3K inhibitor idelalisib.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The present study constructed a prognostic risk score based on FAM gene expression, revealing related immune phenotypic differences and exploring the regulatory role of FAO in CLL development. Targeting fatty acid metabolism potentially modulates the CLL immune microenvironment and synergistically enhances the efficacy of PI3K inhibitors.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40364-025-00753-7","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T15:04:06Z","timestamp":1741791846000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Fatty acid metabolism shapes immune responses in chronic lymphocytic leukemia"],"prefix":"10.1186","volume":"13","author":[{"given":"Yang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosheng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"issue":"1","key":"753_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40164-022-00292-z","volume":"11","author":"Y Nie","year":"2022","unstructured":"Nie Y, Yun X, Zhang Y, Wang X. Targeting metabolic reprogramming in chronic lymphocytic leukemia. Exp Hematol Oncol. 2022;11(1):39. https:\/\/doi.org\/10.1186\/s40164-022-00292-z","journal-title":"Exp Hematol Oncol"},{"issue":"11","key":"753_CR2","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1080\/10428194.2018.1439167","volume":"59","author":"U Rozovski","year":"2018","unstructured":"Rozovski U, Harris DM, Li P, et al. Ibrutinib inhibits free fatty acid metabolism in chronic lymphocytic leukemia. Leuk Lymphoma. 2018;59(11):2686\u201391. https:\/\/doi.org\/10.1080\/10428194.2018.1439167","journal-title":"Leuk Lymphoma"},{"key":"753_CR3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3389\/fonc.2018.00411","volume":"8","author":"G Galicia-V\u00e1zquez","year":"2018","unstructured":"Galicia-V\u00e1zquez G, Aloyz R. Ibrutinib resistance is reduced by an inhibitor of fatty acid oxidation in primary CLL lymphocytes. Front Oncol. 2018;8:411. https:\/\/doi.org\/10.3389\/fonc.2018.00411","journal-title":"Front Oncol"},{"issue":"6","key":"753_CR4","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/sj.leu.2404220","volume":"20","author":"M Bilban","year":"2006","unstructured":"Bilban M, Heintel D, Scharl T, et al. Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression. Leukemia. 2006;20(6):1080\u20138. https:\/\/doi.org\/10.1038\/sj.leu.2404220","journal-title":"Leukemia"},{"issue":"1","key":"753_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/bjh.15751","volume":"185","author":"LA Thurgood","year":"2019","unstructured":"Thurgood LA, Dwyer ES, Lower KM, Chataway TK, Kuss BJ. Altered expression of metabolic pathways in CLL detected by unlabelled quantitative mass spectrometry analysis. Br J Haematol. 2019;185(1):65\u201378. https:\/\/doi.org\/10.1111\/bjh.15751","journal-title":"Br J Haematol"},{"issue":"4","key":"753_CR6","doi-asserted-by":"publisher","first-page":"100987","DOI":"10.1016\/j.xcrm.2023.100987","volume":"4","author":"X Bao","year":"2023","unstructured":"Bao X, Wang D, Dai X, et al. An immunometabolism subtyping system identifies S100A9\u2009+\u2009macrophage as an immune therapeutic target in colorectal cancer based on multiomics analysis. Cell Rep Med. 2023;4(4):100987. https:\/\/doi.org\/10.1016\/j.xcrm.2023.100987","journal-title":"Cell Rep Med"},{"issue":"7754","key":"753_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-019-1118-2","volume":"569","author":"F Veglia","year":"2019","unstructured":"Veglia F, Tyurin VA, Blasi M, et al. Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature. 2019;569(7754):73\u20138. https:\/\/doi.org\/10.1038\/s41586-019-1118-2","journal-title":"Nature"},{"issue":"7","key":"753_CR8","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","volume":"183","author":"AE Ringel","year":"2020","unstructured":"Ringel AE, Drijvers JM, Baker GJ, et al. Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity. Cell. 2020;183(7):1848\u2013e186626. https:\/\/doi.org\/10.1016\/j.cell.2020.11.009","journal-title":"Cell"},{"issue":"3","key":"753_CR9","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1161\/CIRCULATIONAHA.109.888735","volume":"121","author":"JG Duncan","year":"2010","unstructured":"Duncan JG, Bharadwaj KG, Fong JL, et al. Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators. Circulation. 2010;121(3):426\u201335. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.888735","journal-title":"Circulation"},{"issue":"6","key":"753_CR10","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.cmet.2019.04.012","volume":"29","author":"G Godlewski","year":"2019","unstructured":"Godlewski G, Cinar R, Coffey NJ, et al. Targeting peripheral CB1 receptors reduces ethanol intake via a gut-brain axis. Cell Metab. 2019;29(6):1320\u2013e13338. https:\/\/doi.org\/10.1016\/j.cmet.2019.04.012","journal-title":"Cell Metab"},{"issue":"5","key":"753_CR11","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1002\/hep.23861","volume":"52","author":"N Sachithanandan","year":"2010","unstructured":"Sachithanandan N, Fam BC, Fynch S, et al. Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity. Hepatology. 2010;52(5):1632\u201342. https:\/\/doi.org\/10.1002\/hep.23861","journal-title":"Hepatology"},{"issue":"12","key":"753_CR12","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","volume":"111","author":"M Hallek","year":"2008","unstructured":"Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the international workshop on chronic lymphocytic leukemia updating the National Cancer Institute-Working group 1996 guidelines. Blood. 2008;111(12):5446\u201356. https:\/\/doi.org\/10.1182\/blood-2007-06-093906","journal-title":"Blood"},{"issue":"5","key":"753_CR13","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00109-023-02313-8","volume":"101","author":"X Zhang","year":"2023","unstructured":"Zhang X, Han Y, Nie Y, et al. PAX5 aberrant expression incorporated in MIPI-SP risk scoring system exhibits additive value in mantle cell lymphoma. J Mol Med. 2023;101(5):595\u2013606. https:\/\/doi.org\/10.1007\/s00109-023-02313-8","journal-title":"J Mol Med"},{"issue":"1","key":"753_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40164-022-00364-0","volume":"12","author":"X Hu","year":"2023","unstructured":"Hu X, Han Y, Liu J, et al. CTP synthase 2 predicts inferior survival and mediates DNA damage response via interacting with BRCA1 in chronic lymphocytic leukemia. Exp Hematol Oncol. 2023;12(1):6. https:\/\/doi.org\/10.1186\/s40164-022-00364-0","journal-title":"Exp Hematol Oncol"},{"issue":"7","key":"753_CR15","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. https:\/\/doi.org\/10.1093\/nar\/gkv007","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"753_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137. https:\/\/doi.org\/10.1038\/nmeth.3337","journal-title":"Nat Methods"},{"key":"753_CR17","doi-asserted-by":"publisher","unstructured":"Wu T, Hu E, Xu S, et al. ClusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2021;2(3). https:\/\/doi.org\/10.1016\/j.xinn.2021.100141","DOI":"10.1016\/j.xinn.2021.100141"},{"key":"753_CR18","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1016\/j.csbj.2021.06.043","volume":"19","author":"M Andreatta","year":"2021","unstructured":"Andreatta M, Carmona SJ, UCell. Robust and scalable single-cell gene signature scoring. Comput Struct Biotechnol J. 2021;19:3796\u20138. https:\/\/doi.org\/10.1016\/j.csbj.2021.06.043","journal-title":"Comput Struct Biotechnol J"},{"issue":"3","key":"753_CR19","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.cell.2018.05.061","volume":"174","author":"D van Dijk","year":"2018","unstructured":"van Dijk D, Sharma R, Nainys J, et al. Recovering gene interactions from single-cell data using data diffusion. Cell. 2018;174(3):716\u2013e72927. https:\/\/doi.org\/10.1016\/j.cell.2018.05.061","journal-title":"Cell"},{"issue":"7","key":"753_CR20","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1158\/1535-7163.MCT-19-1047","volume":"19","author":"S Kant","year":"2020","unstructured":"Kant S, Kesarwani P, Guastella AR, et al. Perhexiline demonstrates FYN-mediated antitumor activity in glioblastoma. Mol Cancer Ther. 2020;19(7):1415\u201322. https:\/\/doi.org\/10.1158\/1535-7163.MCT-19-1047","journal-title":"Mol Cancer Ther"},{"issue":"34","key":"753_CR21","doi-asserted-by":"publisher","first-page":"e2304895","DOI":"10.1002\/advs.202304895","volume":"10","author":"Z Wu","year":"2023","unstructured":"Wu Z, Zuo X, Zhang W, et al. m6A-Modified circTET2 interacting with HNRNPC regulates fatty acid oxidation to promote the proliferation of chronic lymphocytic leukemia. Adv Sci (Weinh). 2023;10(34):e2304895. https:\/\/doi.org\/10.1002\/advs.202304895","journal-title":"Adv Sci (Weinh)"},{"issue":"5","key":"753_CR22","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1158\/1541-7786.MCR-14-0412","volume":"13","author":"U Rozovski","year":"2015","unstructured":"Rozovski U, Grgurevic S, Bueso-Ramos C, et al. Aberrant LPL expression, driven by stat3, mediates free fatty acid metabolism in CLL cells. Mol Cancer Res. 2015;13(5):944\u201353. https:\/\/doi.org\/10.1158\/1541-7786.MCR-14-0412","journal-title":"Mol Cancer Res"},{"issue":"2","key":"753_CR23","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1182\/blood-2004-08-3344","volume":"106","author":"P Oppezzo","year":"2005","unstructured":"Oppezzo P, Vasconcelos Y, Settegrana C, et al. The LPL\/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia. Blood. 2005;106(2):650\u20137. https:\/\/doi.org\/10.1182\/blood-2004-08-3344","journal-title":"Blood"},{"issue":"6","key":"753_CR24","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.leukres.2013.02.008","volume":"37","author":"E Porpaczy","year":"2013","unstructured":"Porpaczy E, Tauber S, Bilban M, et al. Lipoprotein lipase in chronic lymphocytic leukaemia-strong biomarker with lack of functional significance. Leuk Res. 2013;37(6):631\u20136. https:\/\/doi.org\/10.1016\/j.leukres.2013.02.008","journal-title":"Leuk Res"},{"issue":"3","key":"753_CR25","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/sj.leu.2405058","volume":"22","author":"CP Pallasch","year":"2008","unstructured":"Pallasch CP, Schwamb J, K\u00f6nigs S, et al. Targeting lipid metabolism by the lipoprotein lipase inhibitor Orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells. Leukemia. 2008;22(3):585\u201392. https:\/\/doi.org\/10.1038\/sj.leu.2405058","journal-title":"Leukemia"},{"issue":"5","key":"753_CR26","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/leu.2012.329","volume":"27","author":"DE Spaner","year":"2013","unstructured":"Spaner DE, Lee E, Shi Y, et al. PPAR-alpha is a therapeutic target for chronic lymphocytic leukemia. Leukemia. 2013;27(5):1090\u20139. https:\/\/doi.org\/10.1038\/leu.2012.329","journal-title":"Leukemia"},{"issue":"9","key":"753_CR27","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1210\/jc.2006-0638","volume":"91","author":"GR Steinberg","year":"2006","unstructured":"Steinberg GR, McAinch AJ, Chen MB, et al. The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans. J Clin Endocrinol Metab. 2006;91(9):3592\u20137. https:\/\/doi.org\/10.1210\/jc.2006-0638","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"753_CR28","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.2337\/db05-1404","volume":"55","author":"AL Carey","year":"2006","unstructured":"Carey AL, Steinberg GR, Macaulay SL, et al. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes. 2006;55(10):2688\u201397. https:\/\/doi.org\/10.2337\/db05-1404","journal-title":"Diabetes"},{"key":"753_CR29","doi-asserted-by":"publisher","first-page":"251479","DOI":"10.1155\/2014\/251479","volume":"2014","author":"G Levidou","year":"2014","unstructured":"Levidou G, Sachanas S, Pangalis GA, et al. Immunohistochemical analysis of IL-6, IL-8\/CXCR2 axis, Tyr p-STAT-3, and SOCS-3 in lymph nodes from patients with chronic lymphocytic leukemia: correlation between microvascular characteristics and prognostic significance. Biomed Res Int. 2014;2014:251479. https:\/\/doi.org\/10.1155\/2014\/251479","journal-title":"Biomed Res Int"},{"issue":"19","key":"753_CR30","doi-asserted-by":"publisher","first-page":"28684","DOI":"10.18632\/oncotarget.8760","volume":"7","author":"TL Chen","year":"2016","unstructured":"Chen TL, Gupta N, Lehman A, et al. Hsp90 inhibition increases SOCS3 transcript and regulates migration and cell death in chronic lymphocytic leukemia. Oncotarget. 2016;7(19):28684\u201396. https:\/\/doi.org\/10.18632\/oncotarget.8760","journal-title":"Oncotarget"},{"issue":"26","key":"753_CR31","doi-asserted-by":"publisher","first-page":"5784","DOI":"10.1016\/j.cell.2023.11.017","volume":"186","author":"YY Liao","year":"2023","unstructured":"Liao YY, Zhang H, Shen Q, et al. Snapshot of the cannabinoid receptor 1-arrestin complex unravels the biased signaling mechanism. Cell. 2023;186(26):5784\u2013e579717. https:\/\/doi.org\/10.1016\/j.cell.2023.11.017","journal-title":"Cell"},{"issue":"10","key":"753_CR32","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.cell.2022.04.005","volume":"185","author":"TT Wei","year":"2022","unstructured":"Wei TT, Chandy M, Nishiga M, et al. Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation. Cell. 2022;185(10):1676\u2013e169323. https:\/\/doi.org\/10.1016\/j.cell.2022.04.005","journal-title":"Cell"},{"issue":"3","key":"753_CR33","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s12020-016-1172-6","volume":"55","author":"CO Sidibeh","year":"2017","unstructured":"Sidibeh CO, Pereira MJ, Lau B\u00f6rjesson J, et al. Role of cannabinoid receptor 1 in human adipose tissue for lipolysis regulation and insulin resistance. Endocrine. 2017;55(3):839\u201352. https:\/\/doi.org\/10.1007\/s12020-016-1172-6","journal-title":"Endocrine"},{"issue":"6","key":"753_CR34","doi-asserted-by":"publisher","first-page":"e0156693","DOI":"10.1371\/journal.pone.0156693","volume":"11","author":"P Freund","year":"2016","unstructured":"Freund P, Porpaczy EA, Le T, et al. Cannabinoid receptors are overexpressed in CLL but of limited potential for therapeutic exploitation. PLoS ONE. 2016;11(6):e0156693. https:\/\/doi.org\/10.1371\/journal.pone.0156693","journal-title":"PLoS ONE"},{"issue":"5","key":"753_CR35","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3390\/cancers15051585","volume":"15","author":"M Merrien","year":"2023","unstructured":"Merrien M, Wasik AM, Mel\u00e9n CM, et al. 2-arachidonoylglycerol modulates CXCL12-mediated chemotaxis in mantle cell lymphoma and chronic lymphocytic leukemia. Cancers (Basel). 2023;15(5):1585. https:\/\/doi.org\/10.3390\/cancers15051585","journal-title":"Cancers (Basel)"},{"issue":"5","key":"753_CR36","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/ijc.23584","volume":"123","author":"K Gustafsson","year":"2008","unstructured":"Gustafsson K, Wang X, Severa D, et al. Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation. Int J Cancer. 2008;123(5):1025\u201333. https:\/\/doi.org\/10.1002\/ijc.23584","journal-title":"Int J Cancer"},{"issue":"3","key":"753_CR37","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.celrep.2019.12.074","volume":"30","author":"JG Kang","year":"2020","unstructured":"Kang JG, Lago CU, Lee JE, et al. A mouse homolog of a human TP53 germline mutation reveals a lipolytic activity of p53. Cell Rep. 2020;30(3):783\u2013e7925. https:\/\/doi.org\/10.1016\/j.celrep.2019.12.074","journal-title":"Cell Rep"},{"issue":"11","key":"753_CR38","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.2337\/db22-1027","volume":"72","author":"Y Huang","year":"2023","unstructured":"Huang Y, Hertzel AV, Fish SR, et al. TP53\/p53 facilitates stress-induced exosome and protein secretion by adipocytes. Diabetes. 2023;72(11):1560\u201373. https:\/\/doi.org\/10.2337\/db22-1027","journal-title":"Diabetes"},{"issue":"6","key":"753_CR39","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1159\/000516957","volume":"10","author":"KS Ahn","year":"2021","unstructured":"Ahn KS, O\u2019Brien DR, Kim YH, et al. Associations of serum tumor biomarkers with integrated genomic and clinical characteristics of hepatocellular carcinoma. Liver Cancer. 2021;10(6):593\u2013605. https:\/\/doi.org\/10.1159\/000516957","journal-title":"Liver Cancer"},{"issue":"14","key":"753_CR40","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1182\/blood.2021013926","volume":"139","author":"N Purroy","year":"2022","unstructured":"Purroy N, Tong YE, Lemvigh CK, et al. Single-cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib. Blood. 2022;139(14):2252\u20136. https:\/\/doi.org\/10.1182\/blood.2021013926","journal-title":"Blood"},{"issue":"16","key":"753_CR41","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.1016\/j.cell.2021.05.045","volume":"184","author":"A Wagner","year":"2021","unstructured":"Wagner A, Wang C, Fessler J, et al. Metabolic modeling of single Th17 cells reveals regulators of autoimmunity. Cell. 2021;184(16):4168\u2013e418521. https:\/\/doi.org\/10.1016\/j.cell.2021.05.045","journal-title":"Cell"},{"issue":"1","key":"753_CR42","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.immuni.2020.06.016","volume":"53","author":"S Kumagai","year":"2020","unstructured":"Kumagai S, Togashi Y, Sakai C, et al. An oncogenic alteration creates a microenvironment that promotes tumor progression by conferring a metabolic advantage to regulatory T cells. Immunity. 2020;53(1):187\u2013e2038. https:\/\/doi.org\/10.1016\/j.immuni.2020.06.016","journal-title":"Immunity"},{"issue":"1","key":"753_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.immuni.2020.06.020","volume":"53","author":"N Khatwani","year":"2020","unstructured":"Khatwani N, Turk MJ. Oncogenes feed Treg cells without calling CD8s to the table. Immunity. 2020;53(1):13\u20135. https:\/\/doi.org\/10.1016\/j.immuni.2020.06.020","journal-title":"Immunity"},{"issue":"1","key":"753_CR44","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/s41467-021-21804-1","volume":"12","author":"MH Hung","year":"2021","unstructured":"Hung MH, Lee JS, Ma C, et al. Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma. Nat Commun. 2021;12(1):1455. https:\/\/doi.org\/10.1038\/s41467-021-21804-1","journal-title":"Nat Commun"},{"issue":"11","key":"753_CR45","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.immuni.2022.10.002","volume":"55","author":"BG Nixon","year":"2022","unstructured":"Nixon BG, Kuo F, Ji L, et al. Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer. Immunity. 2022;55(11):2044\u2013e20585. https:\/\/doi.org\/10.1016\/j.immuni.2022.10.002","journal-title":"Immunity"},{"issue":"3","key":"753_CR46","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ccell.2017.08.004","volume":"32","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Kurupati R, Liu L, et al. Enhancing CD8\u2009+\u2009T cell fatty acid catabolism within a metabolically challenging tumor microenvironment increases the efficacy of melanoma immunotherapy. Cancer Cell. 2017;32(3):377\u2013e3919. https:\/\/doi.org\/10.1016\/j.ccell.2017.08.004","journal-title":"Cancer Cell"},{"issue":"11","key":"753_CR47","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa1315226","volume":"370","author":"RR Furman","year":"2014","unstructured":"Furman RR, Sharman JP, Coutre SE, et al. Idelalisib and rituximab in relapsed chronic lymphocytic leukemia. N Engl J Med. 2014;370(11):997\u20131007. https:\/\/doi.org\/10.1056\/NEJMoa1315226","journal-title":"N Engl J Med"},{"issue":"1","key":"753_CR48","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22(1):138. https:\/\/doi.org\/10.1186\/s12943-023-01827-6","journal-title":"Mol Cancer"},{"issue":"7","key":"753_CR49","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41571-022-00633-1","volume":"19","author":"N Vasan","year":"2022","unstructured":"Vasan N, Cantley LC. At a crossroads: how to translate the roles of PI3K in oncogenic and metabolic signalling into improvements in cancer therapy. Nat Rev Clin Oncol. 2022;19(7):471\u201385. https:\/\/doi.org\/10.1038\/s41571-022-00633-1","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"753_CR50","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s43018-021-00218-4","volume":"2","author":"P Castel","year":"2021","unstructured":"Castel P, Toska E, Engelman JA, Scaltriti M. The present and future of PI3K inhibitors for cancer therapy. Nat Cancer. 2021;2(6):587\u201397. https:\/\/doi.org\/10.1038\/s43018-021-00218-4","journal-title":"Nat Cancer"},{"issue":"8","key":"753_CR51","doi-asserted-by":"publisher","first-page":"e003093","DOI":"10.1136\/jitc-2021-003093","volume":"9","author":"P Sun","year":"2021","unstructured":"Sun P, Zhang X, Wang RJ, et al. PI3K\u03b1 inhibitor CYH33 triggers antitumor immunity in murine breast cancer by activating CD8\u2009+\u2009T cells and promoting fatty acid metabolism. J Immunother Cancer. 2021;9(8):e003093. https:\/\/doi.org\/10.1136\/jitc-2021-003093","journal-title":"J Immunother Cancer"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-025-00753-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-025-00753-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-025-00753-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:58:11Z","timestamp":1741827491000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomarkerres.biomedcentral.com\/articles\/10.1186\/s40364-025-00753-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["753"],"URL":"https:\/\/doi.org\/10.1186\/s40364-025-00753-7","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"20 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Medical Ethics Committee of Shandong Provincial Hospital, and each patient gave the informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}